Eastman swings to a loss on restructuring, acquisition charges
12:15 PM MST | February 1, 2013
Eastman Chemical reported a loss of $44 million for the fiscal quarter ended 31 December, compared with $19 million in the year-ago quarter. Excluding one-time items, including costs related to its $4.8-billion acquisition of Solutia last year, earnings jumped 53%, to $1.19/share, meeting analysts' estimates, as reported by Thomson Reuters. Sales climbed 26%, to $2.2 billion. Excluding the addition of Solutia, sales declined 4% on lower selling prices. Eastman increased its adjusted earnings guidance for fiscal year 2013 to $6.30-$6.40/share, up from $5.38/share...
Access is for Chemweek 24/7 PLUS Members ONLY
This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information.
Forgot your user ID or password? Click here to have it sent to you.